Sigrid Therapeutics is a clinical-stage biotechnology company pioneering a new class of therapies to prevent and treat lifestyle diseases
A Little Of Our Story
A Bit of History
Sigrid Therapeutics AB (Sigrid) was founded in 2014 by Prof. Tore Bengtsson and Ms. Sana Alajmovic, with the vision of transforming the way we prevent and treat our modern day chronic lifestyle diseases. The Company’s research dates back to 2008 when Prof. Tore Bengtsson and his research group at the Department of Molecular Biosciences at Stockholm University made discoveries relating to improvements in measurements of metabolic disorders after oral ingestion of engineered silica particles.
The Company has since then developed a novel materials platform technology, SiPore™, which targets lifestyle diseases by changing the way our bodies digest food. The lead product candidate, SiPore15™, is being developed as the first therapy acting in the gut to improve blood sugar levels in people at risk of developing diabetes.
Sigrid is part of the Karolinska Innovations incubator Drive for promising life science startups in Sweden.
”We all know someone afflicted by obesity or diabetes. As such, we at Sigrid never lose sight of our patients as we work relentlessly to advance groundbreaking therapies to improve their lives. We challenge current practice by developing a new class of therapies that change the way we prevent and treat the global epidemics of obesity and diabetes.
Sana AlajmovicCEO & Co-Founder
A Little Of Our Story
Our Team
Sigrid comprises of a multidisciplinary and dynamic team of motivated individuals qualified in the areas of material chemistry and engineering, biochemistry, physiology and preclinical and clinical development.
Sigrid, a female Viking name meaning beautiful victory, was chosen to reflect the ground-breaking potential of our technology and the team’s commitment to advancing novel solutions for the prevention and treatment of our modern day chronic lifestyle diseases.
A Little Of Our Story
Board of Directors
The operational team is supported by Sigrid’s Board of Directors, consisting of seasoned business executives with a track record in pharmaceutical and medical device development and commercialization.
A Little Of Our Story
Advisory Board
Sigrid’s Advisory Board consist of leading scientific and clinical advisors and collaborators within the fields of diabetes, obesity and their related diseases.
Research Collaborations
